A detailed history of Formidable Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Formidable Asset Management, LLC holds 2,271 shares of VRTX stock, worth $1.14 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,271
Previous 2,519 9.85%
Holding current value
$1.14 Million
Previous $1.05 Million 1.14%
% of portfolio
0.18%
Previous 0.18%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $97,416 - $120,411
-248 Reduced 9.85%
2,271 $1.06 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $226,267 - $247,574
555 Added 28.26%
2,519 $1.05 Million
Q4 2023

Feb 07, 2024

SELL
$343.0 - $410.68 $225,351 - $269,816
-657 Reduced 25.07%
1,964 $799,000
Q3 2023

Nov 09, 2023

BUY
$338.18 - $362.46 $60,534 - $64,880
179 Added 7.33%
2,621 $911,000
Q2 2023

Aug 15, 2023

SELL
$314.42 - $351.91 $38,988 - $43,636
-124 Reduced 4.83%
2,442 $859,000
Q1 2023

May 09, 2023

SELL
$283.23 - $323.1 $602,430 - $687,233
-2,127 Reduced 45.32%
2,566 $808,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $29,299 - $32,691
107 Added 2.33%
4,693 $1.36 Million
Q2 2022

Aug 16, 2022

BUY
$234.96 - $292.55 $1.08 Million - $1.34 Million
4,586 New
4,586 $1.29 Million
Q2 2019

Oct 15, 2019

SELL
$164.61 - $190.37 $3.22 Million - $3.73 Million
-19,575 Closed
0 $0
Q1 2019

Oct 15, 2019

BUY
$163.73 - $194.7 $3.21 Million - $3.81 Million
19,575 New
19,575 $938,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.